Boston Common Asset Management’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-33,198
Closed -$6.53M 323
2022
Q4
$6.53M Buy
33,198
+15
+0% +$3.11K 0.31% 100
2022
Q3
$6.16M Sell
33,183
-9,051
-21% -$1.79M 0.32% 94
2022
Q2
$7.57M Buy
42,234
+2,646
+7% +$676K 0.38% 83
2022
Q1
$13.5M Buy
39,588
+225
+0.6% +$76K 0.58% 65
2021
Q4
$14.6M Buy
39,363
+167
+0.4% +$63.3K 0.59% 60
2021
Q3
$15.5M Sell
39,196
-1,354
-3% -$623K 0.67% 53
2021
Q2
$18.7M Buy
+40,550
New +$16.3M 0.8% 47

Other funds holding ILMN

Boston Common Asset Management's ILMN Position: Q1 2023 in Review

Boston Common Asset Management sold out of Illumina (ILMN) in Q1 2023, closing a stake of 33,198 shares — an estimated $6.53M sold.

Boston Common Asset Management first reported a position in ILMN in Q2 2021 and held it in 7 quarters. The position peaked at $18.7M in Q2 2021. 946 funds tracked by Wall St. Rank hold ILMN as of Q1 2023.

  • Boston Common Asset Management reported no remaining Illumina position as of Q1 2023 after selling out during the quarter.
  • Boston Common Asset Management sold 33,198 Illumina shares in Q1 2023, an estimated $6.53M.
  • Boston Common Asset Management first reported a position in Illumina in Q2 2021 and held it in 7 quarters.
  • Boston Common Asset Management's Illumina position peaked at $18.7M in Q2 2021.
  • 946 funds tracked by Wall St. Rank held Illumina as of Q1 2023.

Based on Boston Common Asset Management's 13F filing for Q1 2023, filed 17 May 2023.